391 related articles for article (PubMed ID: 22103762)
1. Industry funded clinical trials: bias and quality.
Del Parigi A
Curr Med Res Opin; 2012 Jan; 28(1):23-5. PubMed ID: 22103762
[TBL] [Abstract][Full Text] [Related]
2. Biased articles.
Friedman JH
Med Health R I; 2009 Mar; 92(3):70. PubMed ID: 19385378
[No Abstract] [Full Text] [Related]
3. Research accountability and financial conflicts of interest in industry-sponsored clinical research: a review.
Tereskerz PM
Account Res; 2003; 10(3):137-58. PubMed ID: 14979317
[No Abstract] [Full Text] [Related]
4. Implications of pharmaceutical industry funding on clinical research.
Lexchin JR
Ann Pharmacother; 2005 Jan; 39(1):194-7. PubMed ID: 15562137
[TBL] [Abstract][Full Text] [Related]
5. Independent medical research.
van der Meer JW; de Gier AM; van Swaaij WP; Katan MB
Neth J Med; 2007 Apr; 65(4):124-6. PubMed ID: 17452759
[No Abstract] [Full Text] [Related]
6. Medical ethics, research and the pharmaceutical industry.
Abud-Mendoza C
Reumatol Clin; 2012; 8(5):233-5. PubMed ID: 22608694
[No Abstract] [Full Text] [Related]
7. Bias in the design, interpretation, and publication of industry-sponsored clinical research.
Hammerschmidt D
Minn Med; 2008 Jun; 91(6):46-7. PubMed ID: 18616022
[No Abstract] [Full Text] [Related]
8. Conflict of interest, disclosure, and trial reports.
Psaty BM
JAMA; 2009 Apr; 301(14):1477-9. PubMed ID: 19351946
[No Abstract] [Full Text] [Related]
9. Managing physician financial conflicts of interest in clinical trials conducted in the private practice setting.
Williams KM
Food Drug Law J; 2004; 59(1):45-77. PubMed ID: 15190925
[No Abstract] [Full Text] [Related]
10. Small study on industry trial sponsorship leads to big questions about quality and bias.
Twombly R
J Natl Cancer Inst; 2007 Jul; 99(13):988-90. PubMed ID: 17596566
[No Abstract] [Full Text] [Related]
11. The potential for bias in reporting of industry-sponsored clinical trials.
Pyke S; Julious SA; Day S; O'Kelly M; Todd S; Matcham J; Seldrup J
Pharm Stat; 2011; 10(1):74-9. PubMed ID: 21275037
[TBL] [Abstract][Full Text] [Related]
12. Conflicts of interest in data monitoring of industry versus publicly financed clinical trials.
Lachin JM
Stat Med; 2004 May; 23(10):1519-21. PubMed ID: 15122730
[TBL] [Abstract][Full Text] [Related]
13. NerveCenter: Office of Inspector General warns NIH on lax COI oversight as many academic medical centers look inward.
Samson K
Ann Neurol; 2010 Mar; 67(3):A7-A10. PubMed ID: 20373337
[No Abstract] [Full Text] [Related]
14. An analysis of the clinical development of drugs in Norway for the years 2000 and 2004: the influence of the pharmaceutical industry.
Winther FO; Hole OP; Nitter-Hauge S
Eur J Clin Pharmacol; 2007 Oct; 63(10):909-12. PubMed ID: 17673994
[TBL] [Abstract][Full Text] [Related]
15. Sponsorship bias in clinical research.
Lexchin J
Int J Risk Saf Med; 2012; 24(4):233-42. PubMed ID: 23135338
[TBL] [Abstract][Full Text] [Related]
16. The perverse consequences of a proposed global tax on research.
MacDonald C; Walton N
Am J Bioeth; 2010 Jun; 10(6):46-7. PubMed ID: 20526972
[No Abstract] [Full Text] [Related]
17. Conflicts of interest with the health industry.
Dubois MY
Pain Med; 2006; 7(5):463-5. PubMed ID: 17014609
[No Abstract] [Full Text] [Related]
18. Medicine in the Noise Age: what can we believe?
Angell M
Account Res; 2001; 8(3):189-95. PubMed ID: 12481786
[No Abstract] [Full Text] [Related]
19. Ten steps to developing a national agenda to address financial conflicts of interest in industry sponsored clinical research.
Tereskerz PM; Moreno J
Account Res; 2005; 12(2):139-55. PubMed ID: 16220626
[TBL] [Abstract][Full Text] [Related]
20. Managing financial conflicts of interest.
IRB; 2003; 25(1):7. PubMed ID: 12833898
[No Abstract] [Full Text] [Related]
[Next] [New Search]
